Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors-Reference-Cited by-同舟云学术

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors

Published:2014-10-29 Issue:5 Volume:121 Page:648-663
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bhatia Smita¹

Affiliation:

1. Department of Population Sciences; City of Hope; Duarte California

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference93 articles.

1. Cancer survivors: living longer, and now, better;Lancet,2004

2. Chronic health conditions in adult survivors of childhood cancer;Oeffinger;N Engl J Med,2006

3. Burden of long-term morbidity after hematopoietic cell transplantation: a report from the bone Marrow Transplant Survivor Study (BMTSS) [abstract];Sun;Blood (ASH Annual Meeting Abstracts),2007

4. Late mortality in survivors of autologous hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study;Bhatia;Blood,2005

5. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study;Mertens;J Natl Cancer Inst,2008

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review;Cancer Epidemiology, Biomarkers & Prevention;2024-05-27

2. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer;Cancer Medicine;2024-05

3. Subsequent malignant neoplasms after primary hematological malignancy in adult patients;International Journal of Cancer;2024-04-25

4. Susceptibility Genes Associated with Multiple Primary Cancers;Cancers;2023-12-10

5. Pan-cancer analysis of the prognostic and immunological role of nucleophosmin/nucleoplasmin 3 (NPM3) and its potential significance in lung adenocarcinoma;Cancer Pathogenesis and Therapy;2023-10